Amphiphilic PEGylated Lanthanide-Doped Upconversion Nanoparticles for Significantly Passive Accumulation in the Peritoneal Metastatic Carcinomatosis Models Following Intraperitoneal Administration.

Inorganic nanoparticles have emerged as attractive materials for cancer research, because of their exceptional physical properties and multifunctional engineering. However, inorganic nanoparticle accumulation in the tumors located in the abdominal cavity after intravenous (IV) administration is confined because of the peritoneum-plasma barrier. To improve this situation, we developed lanthanide-doped upconversion nanoparticles (UCNPs), coated by amphiphilic polyethylene glycol (P-PEG), serving as a representative of inorganic nanoparticles. Following intraperitoneal (IP) administration into the peritoneal metastatic carcinomatosis models, UCNPs coated by P-PEG (P-PEG-UCNPs) passively accumulated in the cancerous tissues at a larger amount than that in the main normal organs. On the basis of spatial proximity, P-PEG-UCNPs administrated via the IP route exhibited higher passive accumulation in the tumors in the abdominal cavity compared to that via the IV route. It is suggested that IP administration could be a promising strategy for inorganic nanoparticles to be efficaciously applied in peritoneal cancer research.

[1]  Laure Dumont,et al.  Influence of Surface Charge and Polymer Coating on Internalization and Biodistribution of Polyethylene Glycol-Modified Iron Oxide Nanoparticles. , 2015, Journal of biomedical nanotechnology.

[2]  Wei Feng,et al.  Core-shell Fe3O4@NaLuF4:Yb,Er/Tm nanostructure for MRI, CT and upconversion luminescence tri-modality imaging. , 2012, Biomaterials.

[3]  Toxicity of Inorganic Nanoparticles Used in Targeted Drug Delivery and Other Biomedical Application: An Updated Account on Concern of Biomedical Nanotoxicology , 2016 .

[4]  R. Steinhardt,et al.  Surface Coating of Nanoparticles Reduces Background Inflammatory Activity while Increasing Particle Uptake and Delivery. , 2017, ACS biomaterials science & engineering.

[5]  Ling Li,et al.  Improving Anti-Tumor Activity of Curcumin by Polymeric Micelles in Thermosensitive Hydrogel System in Colorectal Peritoneal Carcinomatosis Model. , 2015, Journal of biomedical nanotechnology.

[6]  V. Herrera,et al.  Nanoparticle drug-delivery systems for peritoneal cancers: a case study of the design, characterization and development of the expansile nanoparticle. , 2017, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[7]  Yang Yang,et al.  Long-term in vivo biodistribution imaging and toxicity of polyacrylic acid-coated upconversion nanophosphors. , 2010, Biomaterials.

[8]  S. Gambhir,et al.  Nanomaterials for In Vivo Imaging. , 2017, Chemical reviews.

[9]  Scott H. Medina,et al.  Targeting Hepatic Cancer Cells with PEGylated Dendrimers Displaying N‐Acetylgalactosamine and SP94 Peptide Ligands , 2013, Advanced healthcare materials.

[10]  David F. Williams,et al.  Biocompatibility Pathways: Biomaterials-Induced Sterile Inflammation, Mechanotransduction, and Principles of Biocompatibility Control. , 2017, ACS biomaterials science & engineering.

[11]  Chunshui Yu,et al.  Green and facile synthesis of a theranostic nanoprobe with intrinsic biosafety and targeting abilities. , 2016, Nanoscale.

[12]  M. Morgan,et al.  Principles and practice of intraperitoneal chemotherapy for ovarian cancer , 2006, International Journal of Gynecologic Cancer.

[13]  S. Dasari,et al.  Clinical, biopsy, and mass spectrometry findings of renal gelsolin amyloidosis. , 2017, Kidney international.

[14]  J. Zhao,et al.  Lanthanide upconversion luminescence at the nanoscale: fundamentals and optical properties. , 2016, Nanoscale.

[15]  T. Akiba,et al.  Impact of fluvastatin on hyperlipidemia after renal transplantation. , 2004, Transplantation proceedings.

[16]  Wei Feng,et al.  Biodistribution of sub-10 nm PEG-modified radioactive/upconversion nanoparticles. , 2013, Biomaterials.

[17]  Joseph W. Nichols,et al.  Odyssey of a cancer nanoparticle: from injection site to site of action. , 2012, Nano today.

[18]  J. Kinoshita,et al.  Comparative study of the antitumor activity of Nab-paclitaxel and intraperitoneal solvent-based paclitaxel regarding peritoneal metastasis in gastric cancer. , 2014, Oncology reports.

[19]  Mauro Ferrari,et al.  Principles of nanoparticle design for overcoming biological barriers to drug delivery , 2015, Nature Biotechnology.

[20]  B. Wang,et al.  Endothelial dysfunction and inflammation induced by iron oxide nanoparticle exposure: Risk factors for early atherosclerosis. , 2011, Toxicology letters.

[21]  E. Ruoslahti,et al.  iRGD peptide conjugation potentiates intraperitoneal tumor delivery of paclitaxel with polymersomes. , 2016, Biomaterials.

[22]  Brian K. Wilson,et al.  Real-Time and Multiplexed Photoacoustic Imaging of Internally Normalized Mixed-Targeted Nanoparticles. , 2017, ACS biomaterials science & engineering.

[23]  J. Au,et al.  Intraperitoneal therapy for peritoneal cancer. , 2010, Future oncology.

[24]  A Paul Alivisatos,et al.  Cellular effect of high doses of silica-coated quantum dot profiled with high throughput gene expression analysis and high content cellomics measurements. , 2006, Nano letters.

[25]  C. Soto,et al.  Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice. , 2010, Biochemical and biophysical research communications.

[26]  Biqiong Chen,et al.  Efficacy Dependence of Photodynamic Therapy Mediated by Upconversion Nanoparticles: Subcellular Positioning and Irradiation Productivity. , 2017, Small.

[27]  Yujie Xiong,et al.  Modification of NaYF4:Yb,Er@SiO2 Nanoparticles with Gold Nanocrystals for Tunable Green-to-Red Upconversion Emissions , 2011 .

[28]  Yuan Gao,et al.  Water-soluble NaYF4:Yb/Er upconversion nanophosphors: Synthesis, characteristics and application in bioimaging , 2010 .

[29]  R. Zhuo,et al.  Multifunctional Nanotherapeutics with All-in-One Nanoentrapment of Drug/Gene/Inorganic Nanoparticle. , 2016, ACS applied materials & interfaces.

[30]  Sandra N. Ekdawi,et al.  Development of a liposome formulation for improved biodistribution and tumor accumulation of pentamidine for oncology applications. , 2015, International journal of pharmaceutics.

[31]  Brandon Da Silva,et al.  Intra-arterial infusion of PEGylated upconversion nanophosphors to improve the initial uptake by tumors in vivo , 2014 .

[32]  Juanjuan Peng,et al.  Near‐Infrared Photoregulated Drug Release in Living Tumor Tissue via Yolk‐Shell Upconversion Nanocages , 2014 .

[33]  D. Xing,et al.  In Vivo Near-Infrared Photodynamic Therapy Based on Targeted Upconversion Nanoparticles. , 2015, Journal of biomedical nanotechnology.

[34]  M. Ozmen,et al.  Subacute toxicity of uranyl acetate in Swiss-Albino mice. , 1998, Environmental toxicology and pharmacology.

[35]  Wei Feng,et al.  Upconversion luminescent materials: advances and applications. , 2015, Chemical reviews.

[36]  Xiaoyang Xu,et al.  Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. , 2014, Advanced drug delivery reviews.

[37]  H. Dai,et al.  PEG branched polymer for functionalization of nanomaterials with ultralong blood circulation. , 2009, Journal of the American Chemical Society.

[38]  Hua Tang,et al.  Thermosensitive hydrogel system assembled by PTX-loaded copolymer nanoparticles for sustained intraperitoneal chemotherapy of peritoneal carcinomatosis. , 2016, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[39]  Pei-Xun Liu,et al.  Toxicologic effects of gold nanoparticles in vivo by different administration routes , 2010, International journal of nanomedicine.

[40]  Thomas Nann,et al.  A four-color colloidal multiplexing nanoparticle system. , 2008, ACS nano.

[41]  Nitish Thakor,et al.  Size and Shell Effects on the Photoacoustic and Luminescence Properties of Dual Modal Rare-Earth-Doped Nanoparticles for Infrared Photoacoustic Imaging. , 2016, ACS biomaterials science & engineering.

[42]  Ze Lu,et al.  Effects of Carrier on Disposition and Antitumor Activity of Intraperitoneal Paclitaxel , 2007, Pharmaceutical Research.

[43]  Yunxin Liu,et al.  Upconversion luminescence turning of NaREF4 (RE=0.4Y+0.4La+0.2 (Yb, Er, Tm)) nanoparticles and their applications for detecting Rhodamine B in shrimp , 2017 .

[44]  Stephen Clarke,et al.  Pharmacokinetics and Pharmacodynamics of Intraperitoneal Cancer Chemotherapeutics , 2012, Clinical Pharmacokinetics.

[45]  G. Nowak,et al.  The influence of the route of administration of gold nanoparticles on their tissue distribution and basic biochemical parameters: In vivo studies , 2015, Pharmacological reports : PR.

[46]  Yuliang Zhao,et al.  Biodistribution, excretion, and toxicity of polyethyleneimine modified NaYF4:Yb,Er upconversion nanoparticles in mice via different administration routes. , 2017, Nanoscale.

[47]  Qian Liu,et al.  Multifunctional rare-earth self-assembled nanosystem for tri-modal upconversion luminescence /fluorescence /positron emission tomography imaging. , 2011, Biomaterials.

[48]  Jiwon Bang,et al.  Surface engineering of inorganic nanoparticles for imaging and therapy. , 2013, Advanced drug delivery reviews.

[49]  Wei Feng,et al.  In vivo biodistribution and toxicity assessment of triplet-triplet annihilation-based upconversion nanocapsules. , 2017, Biomaterials.

[50]  Wei Feng,et al.  Sub-10 nm hexagonal lanthanide-doped NaLuF4 upconversion nanocrystals for sensitive bioimaging in vivo. , 2011, Journal of the American Chemical Society.

[51]  S. Sivakumar,et al.  Targeted Stealth Polymer Capsules Encapsulating Ln3+-Doped LaVO4 Nanoparticles for Bioimaging Applications. , 2016, ACS biomaterials science & engineering.

[52]  Feuser Paulo Emilio,et al.  In Vitro Cytotoxicity of Poly(Methyl Methacrylate) Nanoparticles and Nanocapsules Obtained by Miniemulsion Polymerization for Drug Delivery Application , 2016 .

[53]  Sumaira Ashraf,et al.  In vivo degeneration and the fate of inorganic nanoparticles. , 2016, Chemical Society reviews.

[54]  T. Hyeon,et al.  Recent Advances in Inorganic Nanoparticle-Based NIR Luminescence Imaging: Semiconductor Nanoparticles and Lanthanide Nanoparticles. , 2017, Bioconjugate chemistry.

[55]  S. Spiegel,et al.  Host sphingosine kinase 1 worsens pancreatic cancer peritoneal carcinomatosis. , 2016, The Journal of surgical research.

[56]  E. Reimhult,et al.  Interaction of Size-Tailored PEGylated Iron Oxide Nanoparticles with Lipid Membranes and Cells. , 2017, ACS biomaterials science & engineering.

[57]  Tiago Morais,et al.  Short- and long-term distribution and toxicity of gold nanoparticles in the rat after a single-dose intravenous administration. , 2014, Nanomedicine : nanotechnology, biology, and medicine.

[58]  S. D. De Smedt,et al.  Nanomedicine‐based intraperitoneal therapy for the treatment of peritoneal carcinomatosis — Mission possible?☆ , 2017, Advanced drug delivery reviews.

[59]  Kai Yang,et al.  In vivo pharmacokinetics, long-term biodistribution, and toxicology of PEGylated graphene in mice. , 2011, ACS nano.